John F. Heerdink, Jr.
San Francisco, California, United States
7K followers
500+ connections
View mutual connections with John F.
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with John F.
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Activity
7K followers
-
John F. Heerdink, Jr. shared thisChasing Vibes or Buying an AI Moat? OpenAI’s ‘Tech bros’ TBPN Deal ExplainedChasing Vibes or Buying an AI Moat? OpenAI’s 'Tech bros' TBPN Deal Explained - Vista Partners LLC | HomeVista Partners LLCChasing Vibes or Buying an AI Moat? OpenAI’s 'Tech bros' TBPN Deal Explained - Vista Partners LLC | HomeVista Partners LLC
-
John F. Heerdink, Jr. shared thisGood Friday’s US Jobs Report Surprise: 82k New Healthcare Jobs Give the Economy a Second Opinion -( $FIGS $QQQ $SPY $DIA ) https://lnkd.in/gd_PVNd7 #USJobsReport #JobsReportSurprise #HealthcareJobs #HealthcareHiring #LaborMarket #EmploymentData #GoodFridayJobs #HealthcareBoom #MedicalWorkers #NursingJobs #HospitalJobs #OutpatientCare #HomeHealth #EconomicOutlook #SoftLanding #FIGS #FIGSstock #HealthcareInvesting #WallStreet #MainStreet #JobGrowth #NonfarmPayrolls #USEconomy #LaborMarketTrends #HealthcareSector #DefensiveGrowth #MacroTrends #Workforce #MedicalApparel #Scrubs #HealthServices #AgingPopulation #DemographicTrends #MarketSentiment #Investing #JobsReportAnalysisGood Friday's US Jobs Report Surprise: 82k New Healthcare Jobs Give the Economy a Second Opinion -( $FIGS $QQQ $SPY $DIA ) - Vista Partners LLC | HomeVista Partners LLCGood Friday's US Jobs Report Surprise: 82k New Healthcare Jobs Give the Economy a Second Opinion -( $FIGS $QQQ $SPY $DIA ) - Vista Partners LLC | HomeVista Partners LLC
-
John F. Heerdink, Jr. reposted thisSpaceX’s ‘Quiet’ Countdown to Wall Street: A ‘Confidential’ IPO With Cosmic Ambition -( $TSLA ) https://lnkd.in/gdXY6QfrSpaceX’s 'Quiet' Countdown to Wall Street: A 'Confidential' IPO With Cosmic Ambition -( $TSLA ) - Vista Partners LLC | HomeVista Partners LLCSpaceX’s 'Quiet' Countdown to Wall Street: A 'Confidential' IPO With Cosmic Ambition -( $TSLA ) - Vista Partners LLC | HomeVista Partners LLC
-
John F. Heerdink, Jr. shared thisWar, Oil, Repeat: Why Markets Treat The Iran Crisis Like A Sequel With The Same Ending -( $DIA $QQQ $SPY $VIX ) A wave of #StockMarket volatility tied to #Iran tensions continues to ripple through #WallStreet as traders weigh #Geopolitics, #OilPrices, and #InflationRisk against resilient #CorporateEarnings, surging #AI and #TechStocks, and expectations for future #InterestRates and #FedPolicy, creating a recurring cycle of #RiskOn #RiskOff sentiment that feels like #DejaVu for #Investors, #Traders, and #PortfolioManagers navigating constant #MarketHeadlines and searching for #BuyingOpportunities amid #MarketVolatility and #GlobalMarkets uncertainty. Learn more... https://lnkd.in/g7WyyMk8War, Oil, Repeat: Why Markets Treat The Iran Crisis Like A Sequel With The Same Ending -( $DIA $QQQ $SPY $VIX ) - Vista Partners LLC | HomeVista Partners LLCWar, Oil, Repeat: Why Markets Treat The Iran Crisis Like A Sequel With The Same Ending -( $DIA $QQQ $SPY $VIX ) - Vista Partners LLC | HomeVista Partners LLC
-
John F. Heerdink, Jr. shared thisApril 1, 2026 – Stocks Launch April Rally on Hopes of Iran War Off‑Ramp and Softer Oil – ( $EPRX $GOVX $MODD $MTWO $NOK $NVDA $SER $SOAR $TSLA Rise! https://lnkd.in/gzkq7GUuApril 1, 2026 - Stocks Launch April Rally on Hopes of Iran War Off‑Ramp and Softer Oil - ( $EPRX $GOVX $MODD $MTWO $NOK $NVDA $SER $SOAR $TSLA Rise!) - Vista Partners LLC | HomeVista Partners LLCApril 1, 2026 - Stocks Launch April Rally on Hopes of Iran War Off‑Ramp and Softer Oil - ( $EPRX $GOVX $MODD $MTWO $NOK $NVDA $SER $SOAR $TSLA Rise!) - Vista Partners LLC | HomeVista Partners LLC
-
John F. Heerdink, Jr. shared thisSpaceX’s ‘Quiet’ Countdown to Wall Street: A ‘Confidential’ IPO With Cosmic Ambition -( $TSLA ) https://lnkd.in/gdXY6QfrSpaceX’s 'Quiet' Countdown to Wall Street: A 'Confidential' IPO With Cosmic Ambition -( $TSLA ) - Vista Partners LLC | HomeVista Partners LLCSpaceX’s 'Quiet' Countdown to Wall Street: A 'Confidential' IPO With Cosmic Ambition -( $TSLA ) - Vista Partners LLC | HomeVista Partners LLC
-
John F. Heerdink, Jr. shared thisExcited to share our latest Tribe Public CEO Presentation + Q&A Webinar Event Video, “Turning EoE Into a Once-a-Year Appointment,” featuring James A. Helliwell, M.D., CEO and Co-founder of Eupraxia Pharmaceuticals (NASDAQ: EPRX). 🎥 Watch the full event here: https://lnkd.in/grYgPJmd Dr. Helliwell shared how Eupraxia is leveraging its Diffusphere™ precision delivery platform to advance long-acting therapies for Eosinophilic Esophagitis (EoE)—an inflammatory disease affecting more than 500,000 people in the U.S. His clinical insights and biotech leadership made for a dynamic discussion during both the presentation and Q&A session. Eupraxia Pharmaceuticals is a clinical-stage biotechnology company developing locally delivered, extended-release medicines designed to drive better patient outcomes through targeted, sustained therapy in high unmet-need indications. Learn more at www.eupraxiapharma.com. If you haven’t joined one of our Tribe Public events yet, our corporate-sponsored webinars and in-person sessions offer direct corporate access for investors, advisors, family offices, and media professionals across 41 U.S. cities. Discover more and join the Tribe at www.TribePublic.com. #TribePublic #EupraxiaPharmaceuticals #EPRX #Biotech #HealthcareInnovation #EosinophilicEsophagitis #EoE #PrecisionMedicine #DrugDelivery #Diffusphere #ClinicalTrials #Phase2 #MedicalResearch #Biotechnology #HealthcareInvesting #LifeSciences #InvestorAccess #CorporateAccess #WebinarEvent #BiotechLeadership #Pharma #MedTech #HealthcareTechnology #PatientOutcomes #Osteoarthritis #InnovationInMedicine #TribeEvents #PublicMarkets #InvestorRelations #BiotechNews #MedicalBreakthroughs #TorontoStockExchange #CEOInsights #HealthcareCommunity
-
John F. Heerdink, Jr. reposted thisPlease join us as we are excited to kick off April with a powerful Tribe Public CEO Presentation & Q&A Webinar tomorrow, Wednesday, April 1 at 8:00am PT / 11:00am ET. The session is titled: "Turning EOE Into a Once-a-Year Appointment.” We’ll be joined by James A. Helliwell, M.D., Co-founder and CEO of Eupraxia Pharmaceuticals (NASDAQ: EPRX), who will deliver a short presentation followed by a focused 5–10 minute Q&A. This fast-moving, 30-minute format is designed so you can plug in, learn, and get back to your day with new insights. If you’ve already registered, you’re all set—just add it to your calendar and join us tomorrow. If you haven’t yet, register here today: https://lnkd.in/g8cbmWTg. You are also welcome to submit questions in advance for Dr. Helliwell at research@tribepublic.com, or drop them directly into the Zoom chat during the event. Feel free to invite a colleague or friend who would value direct access to an innovative biotech leadership team. ABOUT EOE: Eosinophilic Esophagitis (EoE) is an inflammatory-mediated disease in which white blood cells migrate into and become trapped in the esophagus, creating pain and difficulty with swallowing food. According to market research from Clearview, EoE affects more than 500,000 people in the United States and has been identified by the American Gastroenterological Association as rapidly increasing in both incidence and prevalence. Impacts from both symptoms & interventions frequently lead to mental health issues, compounding the disease burden of EoE for both the healthcare system and the individual. #EoE #EosinophilicEsophagitis #Biotech #Biotechnology #ClinicalTrials #DrugDelivery #PrecisionMedicine #ExtendedRelease #Gastroenterology #HealthcareInnovation #MedicalResearch #LifeSciences #Osteoarthritis #Corticosteroid #MicroSphereTechnology #EOETreatment #BiotechInvesting #HealthcareInvesting #EPRX #Eupraxia #EupraxiaPharmaceuticals #CEO #Leadership #Webinar #InvestorWebinar #TribePublic #InvestorCommunity #MedicalDevices #Arthrotap #InnovationInMedicine #PatientOutcomes #ChronicDisease #RareDisease #HealthcareEcosystem #CapitalMarkets #TorontoStockExchange #TSX #PublicCompany #Pharma #MedTechWelcome! You are invited to join a webinar: Tribe Public Event - Wednesday, April 1, 2026 - "Turning EOE Into a Once-a-Year Appointment" . After registering, you will receive a confirmation email about joining the webinar.Welcome! You are invited to join a webinar: Tribe Public Event - Wednesday, April 1, 2026 - "Turning EOE Into a Once-a-Year Appointment" . After registering, you will receive a confirmation email about joining the webinar.
-
John F. Heerdink, Jr. reposted thisPlease join us as we are excited to kick off April with a powerful Tribe Public CEO Presentation & Q&A Webinar tomorrow, Wednesday, April 1 at 8:00am PT / 11:00am ET. The session is titled: "Turning EOE Into a Once-a-Year Appointment.” We’ll be joined by James A. Helliwell, M.D., Co-founder and CEO of Eupraxia Pharmaceuticals (NASDAQ: EPRX), who will deliver a short presentation followed by a focused 5–10 minute Q&A. This fast-moving, 30-minute format is designed so you can plug in, learn, and get back to your day with new insights. If you’ve already registered, you’re all set—just add it to your calendar and join us tomorrow. If you haven’t yet, register here today: https://lnkd.in/g8cbmWTg. You are also welcome to submit questions in advance for Dr. Helliwell at research@tribepublic.com, or drop them directly into the Zoom chat during the event. Feel free to invite a colleague or friend who would value direct access to an innovative biotech leadership team. ABOUT EOE: Eosinophilic Esophagitis (EoE) is an inflammatory-mediated disease in which white blood cells migrate into and become trapped in the esophagus, creating pain and difficulty with swallowing food. According to market research from Clearview, EoE affects more than 500,000 people in the United States and has been identified by the American Gastroenterological Association as rapidly increasing in both incidence and prevalence. Impacts from both symptoms & interventions frequently lead to mental health issues, compounding the disease burden of EoE for both the healthcare system and the individual. #EoE #EosinophilicEsophagitis #Biotech #Biotechnology #ClinicalTrials #DrugDelivery #PrecisionMedicine #ExtendedRelease #Gastroenterology #HealthcareInnovation #MedicalResearch #LifeSciences #Osteoarthritis #Corticosteroid #MicroSphereTechnology #EOETreatment #BiotechInvesting #HealthcareInvesting #EPRX #Eupraxia #EupraxiaPharmaceuticals #CEO #Leadership #Webinar #InvestorWebinar #TribePublic #InvestorCommunity #MedicalDevices #Arthrotap #InnovationInMedicine #PatientOutcomes #ChronicDisease #RareDisease #HealthcareEcosystem #CapitalMarkets #TorontoStockExchange #TSX #PublicCompany #Pharma #MedTechWelcome! You are invited to join a webinar: Tribe Public Event - Wednesday, April 1, 2026 - "Turning EOE Into a Once-a-Year Appointment" . After registering, you will receive a confirmation email about joining the webinar.Welcome! You are invited to join a webinar: Tribe Public Event - Wednesday, April 1, 2026 - "Turning EOE Into a Once-a-Year Appointment" . After registering, you will receive a confirmation email about joining the webinar.
-
John F. Heerdink, Jr. liked thisJohn F. Heerdink, Jr. liked thisSomething I've learned after a decade of building diabetes education programs: 📋❌ The most technically accurate content can still completely miss the patient. Because information without context isn't education. I've seen it happen across every format: professional trainings, conference symposiums, clinical programs, support groups, social media outreach. You can have the most evidence-based content in the room and still lose people in the first five minutes. Why? Because real education meets people where they are. Their health literacy level. Their emotional state. Their cultural background. Their history with the healthcare system — and whether they trust it. That's the foundation of everything I build. 💡 At #ADCES2025, I had the opportunity to design and lead a full Product Theatre program built around 4 real patient profiles — each representing different factors that shape how a person with diabetes actually experiences insulin pump therapy. T1D and T2D. Different technology comfort levels. Different socioeconomic contexts. Different emotional readiness. Because "one size fits all" has never worked in diabetes care. The programs I create are designed to: 🌟 Translate complex clinical concepts into clear, practical takeaways for HCPs, nurses, and educators 🌟 Reduce cognitive burden and diabetes distress — not add to it 🌟 Ground scientific evidence in lived patient experience 🌟 Give providers the confidence to have better, deeper conversations It's not just what to teach. It's how it will land — and who it needs to reach. The most effective medical education doesn't start with data. It starts with understanding the people behind it. If you're in medical affairs, medical education, or diabetes care — what's the biggest gap you see between clinical content and patient understanding? I'd genuinely love to hear it. 👇 #MedicalAffairs #DiabetesEducation #HealthcareLeadership #MedicalEducation #PatientCenteredCare #T1D #InsulinPumpTherapy #ADCES #DiabetesTechnology #PersonWithDiabetes
-
John F. Heerdink, Jr. liked thisJohn F. Heerdink, Jr. liked thisLast Thursday’s Volunteers of America Changemakers event brought together community leaders, advocates, and partners committed to strengthening our region while celebrating 130 years of Volunteers of America’s impact in Portland. The evening served as a reminder of our shared responsibility to show up, listen, and invest in partnerships that advance dignity, stability, and opportunity for those we serve. Thank you to the organizers and speakers who reminded us that real change is built through collaboration, commitment, and community. https://lnkd.in/gnbkZHA3
View John F.’s full profile
-
See who you know in common
-
Get introduced
-
Contact John F. directly
Other similar profiles
Explore more posts
-
John F. Heerdink, Jr.
7K followers
Insulet’s Growth Spurt Meets Modular’s Regulatory Push -( $PODD $MODD $ABT $DXCM ) https://lnkd.in/eBcxcynV Insulet’s surge in the patch pump market and Modular Medical’s regulatory advances are at the epicenter of the diabetes tech revolution, as innovative players like #PODD (Insulet), #MODD (Modular Medical), #ABT (Abbott), and #DXCM (Dexcom) compete to expand access to smart insulin pumps and continuous glucose monitors. The FDA pathway, #510k submissions, and IRB approvals highlight the fierce race for next-generation, user-friendly devices aimed at better glycemic control, with recent market momentum driven by #Type2Diabetes solutions, #T2D, #CGM technology, automated insulin delivery, and the shift toward simplicity and affordability for underserved populations. #DiabetesTechnology, #WearableDevices, #InsulinDelivery, #DigitalHealth, #MedTech, #RegulatoryMilestones, and #HealthcareInnovation, all shaping the future for investors and patients in a rapidly growing, value-driven sector.
-
Bhuta Shah & Co LLP | Chartered Accountants
9K followers
The proposed 18.5% AMT on all LLPs and partnership firms—regardless of deductions—could reshape investment structures for startups, family offices, and promoter-led entities. While LLPs have long been favored for their tax efficiency, this shift raises concerns. The Select Committee’s report suggests this change may be unintended, calling for a clarification in the final Income Tax Bill, 2025. If left unaddressed, it may discourage the use of LLPs for genuine investment purposes, despite their acceptance under SEBI and IFSCA norms. To read the full article, click the link below: https://lnkd.in/dxYbSk4N Hemen Asher #IncomeTax2025 #LLP #AMT #TaxUpdate #Startups #FamilyOffice #BhutaShahAndCoLLP #PolicyWatch #FinanceIndia #InvestmentStrategy
5
-
Kit Yu
33K followers
Headline LT flows, while largely known, were -$2bn of outflows (~-$27bn of inflows net of $29bn in reinvested distributions) and included ~$7bn of outflows related to Western. Excluding Western outflows, BEN saw inflows of $5bn during the quarter. Overall, LT inflows (including the benefit of reinvested distributions) were driven by Equities (+$19.8bn), Multi Asset (+$4.0bn), Alternatives (+$6.6bn), partially offset by Fixed Income (-$2.4bn, or +$2.6bn excluding Western). Within Alts, BEN raised $9.5bn in Private Markets in the quarter (relative to $7.2bn last quarter and $22.9bn in F2025), representing ~16% annualized organic growth on $254.7bn of private markets AUM. In terms of other forward indicators, BEN's Institutional pipeline remained flat q/q at $20.4bn.
1
-
Altvia
5K followers
Fundraising cycles are longer. LP scrutiny is higher. And the firms that win allocations today aren’t the ones who “start raising” when Fund IV kicks off. They’re the ones who stay ready every single day. Here's why operational excellence, connected data, and daily investor readiness are now the strongest differentiators in private capital—plus what leading firms do differently. 👉 Read the blog: The Firms That Raise Every Day https://hubs.la/Q03ZQZYS0 #RaiseEveryDay #PrivateCapital #IRExcellence #Fundraising
17
-
Macroaxis LLC
837 followers
Optimized Investment Portfolio: Xtrackers California ($CA), AutoNation ($AN), Merck ($MRK), Kimberly Clark ($KMB), US Bancorp ($USB), Eli Lilly ($LLY), Amphenol ($APH), Thermo Fisher ($TMO), Huntington Bancshares ($HBAN), Community West ($CWBC), Cathay General ($CATY), and Prudential Financial ($PRU): A diversified U.S. equity mix could include Xtrackers California ($CA), AutoNation ($AN), Merck ($MRK), Kimberly Clark ($KMB), US Bancorp ($USB), Eli Lilly ($LLY), Amphenol ($APH), Thermo Fisher ($TMO), Huntington Bancshares ($HBAN), Community West ($CWBC), Cathay General ($CATY), and Prudential Financial ($PRU). https://lnkd.in/gm52-hTe
-
Concentric Innovation
386 followers
Concentric’s precision-led framework turns customization into something that can be delivered at scale. InvestmentNews article, "Custom portfolios at scale...," breaks down the infrastructure behind managing portfolios at the tax-lot level and the discipline required to implement. Learn more about why Concentric emphasizes managing assets at every level here: https://bit.ly/483us4g #Concentric #AssetManagement
21
-
George Mena
iCFO Capital Palm Springs, LLC • 7K followers
Smart founders don’t just raise capital, they protect their cap table while they do it. If you’re giving up too much equity too early, your future rounds will be expensive. iCFO Capital Global works with founders to secure equity capital through disciplined SPV structuring and investor matching, while preserving your long-term value. Raise capital. Keep control. → Apply for prequalification here: https://lnkd.in/gyFJFsjq #FounderFunding #CapTable #EquityCapital
-
AltsWire
6K followers
CAIS Partners With Solactive to Launch Private Credit BDC Index Alternative investment platform CAIS announced the launch of the Solactive CAIS Private Credit BDC Index, or CAISCRED. Available through CAIS’ registered investment adviser CAIS Advisors LLC, in partnership with global index provider Solactive, CAISCRED is a first-of-its-kind index designed to provide a transparent, rules-based benchmark for private credit exposure via perpetual non-traded business development companies. Read the full story on AltsWire: https://lnkd.in/gzaNsvVs Neil Blundell Steffen Scheuble Solactive AG
2
-
Accru Group Inc
152 followers
Not Sure When (or How) to Pay the FTB? Start Here. 💡 California business owners—navigating your tax obligations with the Franchise Tax Board (FTB) can feel overwhelming, but it doesn’t have to be. 📘 Our latest guide breaks it all down: ✅ Key due dates ✅ How to make a payment ✅ Common pitfalls to avoid ✅ What to do if you’ve missed a deadline 👉 Read the full article: https://lnkd.in/gCvu3nWn At Accru Group, we help international and local businesses stay on top of complex U.S. tax rules—so you can focus on what matters most: running your business. #CaliforniaBusiness #TaxTips #FTB #BusinessTax #InternationalTax #AccruGroup
1
-
Portfolio Construction Forum
1K followers
Forget the gap - mind the private equity chasm in portfolios - Watch Five V Capital's Ed Bigazzi on Portfolio Construction Forum and earn 0.50 CE/CPD hrs https://lnkd.in/gqiiU_S3 #PortfolioForum #Strategies #Markets #Equities #Stocks #PrivateEquity #AustralianPrivateEquity #PublicMarkets #MidMarketPrivateEquity #BSBTech
8
-
WealthWise
981 followers
Robinhood Markets filed plans with the SEC to launch Robinhood Ventures Fund I, a closed-end fund aimed at giving retail investors access to private companies. If approved, the fund will trade on the NYSE under ticker RVI. The move underscores Robinhood’s strategy to expand beyond public markets. #HOOD #Robinhood #HOODStock #HOODNews #HOODStockNews #RobinhoodStock #RobinhoodNews #RobinhoodStockNews #Investing #PrivateMarkets #Finance #Stocks #WallStreet #Investors #RVI #SEC #Trading #MarketIntelligence #FinancialMarkets $HOOD
-
CoinResearch AI
189 followers
Circle’s IPO Could Imply a $316B Valuation for Tether? As Circle prepares to finalize its IPO pricing—likely valuing the company north of $7.2B—analysts are using it as a benchmark to extrapolate Tether.io’s potential valuation. 📊 Circle’s valuation is ~11.7% of Usdc’s $61.4B market cap. 💡 Applied to Tether, that ratio implies an ~$18B valuation. 💰 But Tether made ~$13B in 2024 profits, vs. Circle’s $156M. 🧮 Apply profit-based multiples? Tether could be worth $316B. This wide disparity highlights how revenue models, transparency, and risk profiles shape valuations differently across stablecoin giants. Meanwhile, an anonymous $31M Bitcoin donation to Ross Ulbricht’s wallet (via a mixer) sparked headlines over the weekend. Identity unknown—but it marks the largest contribution since his sentencing. 👀 The stablecoin wars aren’t just about peg stability—they're also about public perception, profits, and who commands institutional trust. #CryptoNews #Stablecoins #CircleIPO #Tether #Web3Finance #CryptoValuations #BlockchainAnalysis #USDC #USDT #Bitcoin #RossUlbricht #CryptoMarkets #Fintech
6
-
MaloneBailey, LLP
4K followers
2025 FASB Investor Outreach Report. Check out FASB's fifth annual investor input, which "helped shape standards on digital assets, software costs, and more. With over 2,100 investor interactions since 2021," FASB remains "committed to meaningful engagement and improving financial reporting." (FASB.org) Click below to read more. 👉 https://lnkd.in/ggeSSUF5 #malonebailey #fasb #leadership #accounting #houstoncpafirm #cpalife #business
2
-
Beach Street Legal LLC
192 followers
There is one silver lining for SEC-registered advisers that are now below $90M in AUM due to the recent market dip, and worried they may have to transition to state registration: You have until the time you file your 2026 annual ADV amendment to hit at least $90M in AUM to remain registered with the SEC. You can even dip to $1 in AUM during the year and remain registered with the SEC. The only point in time that matters for purposes of assessing whether you must transition from SEC to state registration is when you file your annual ADV amendment each year. And there's even a further grace period: An SEC-registered adviser that reports less than $90M in AUM as part of its annual ADV amendment filing has 180 days from its fiscal year end (i.e., the end of June, assuming a 12/31 FYE) to achieve at least $90M in AUM and remain registered with the SEC. This is all described in detail in my past article, "Switching Between State And SEC Registration: Evaluating Options (And Requirements) For RIAs Nearing $100 Million RAUM "
1
-
LSEG Data & Analytics
247K followers
Big changes to SEC Round Lot regulations are now in effect. The SEC’s updated Round Lot Regulation which came into effect on November 3, for the Consolidated Tapes (NASDAQ UTP and NYSE CTA) introduced a tiered definition of round lots for NMS stocks. Quote sizes are now displayed in actual share quantities, rather than round lots. These are being rounded down to the nearest multiple of the new round lot size, based on the stock’s price: • $0–$250 → 100 shares • $250.01–$1,000 → 40 shares • $1,000.01–$10,000 → 10 shares • $10,000.01+ → 1 share Learn what this means for your trading workflows in our on-demand webinar: https://lseg.group/4hKdJaG Interested in the upcoming 2026 US Equity regulatory changes? Keep an eye out for corresponding LSEG Academy webinars.
11
-
CSA Partners
2K followers
🚨 Most investors never hear about these write-offs — until it’s too late. In this new podcast, Toby Mathis sits down with cost segregation expert Chris Streit to break down two high-impact depreciation strategies most accountants overlook: 🔹 Partial Asset Dispositions (PAD) 🔹 Qualified Improvement Property (QIP) Here’s why this matters ⬇️ 🏗 PAD lets you fully write off removed components, like an old roof, with no depreciation recapture when done correctly. 🛠 QIP can unlock 100% bonus depreciation for qualifying improvements placed in service after January 20, 2025, including commercial properties and certain short-term rentals. The big takeaway? Cost segregation isn’t a one-and-done event. Strategic depreciation continues after acquisition, especially if you’re renovating, repositioning, or converting properties. If you’re a landlord, investor, or advisor planning improvements, this conversation could meaningfully change your cash-flow and tax planning approach. 🎧 Watch the full discussion here: https://lnkd.in/gjpsQi-a Request a fully engineered Cost Segregation Benefit Analysis: https://lnkd.in/gdxmRsT4 #RealEstateInvesting #CostSegregation #TaxStrategy #PAD #QIP #BonusDepreciation #RealEstateTax #InvestSmart #CSAPartners
16
2 Comments -
Investment Adviser Association
6K followers
Today, the Investment Adviser Association submitted a comment letter strongly supporting the SEC’s proposal to modernize the definition of a “small entity” for investment advisers for purposes of the agency’s analysis of the impact of its rules. The investment adviser industry is overwhelmingly made up of small firms, yet the SEC’s current definition of what’s “small” captures only about 3% of SEC-registered advisers. This significantly limits, the SEC’s ability to fully evaluate how new rules affect the firms actually subject to them. The IAA applauds the SEC’s thoughtful proposal, which would would increase the regulatory assets under management (RAUM) threshold for what’s considered small from $25 million to $1 billion and introduce inflation adjustments. According to the SEC, this update would allow approximately 75% of advisers to be included in the Commission’s small-entity analysis. The IAA strongly supports this change, which reflects our long-standing advocacy, including in a 2023 rulemaking petition urging the SEC to modernize the definition. Updating this threshold will help ensure that future rulemakings are informed by more realistic, data-driven assessments of regulatory impacts on smaller advisers. Read our comment letter: https://lnkd.in/eQrcAzZQ
18
-
Corporate Finance Institute® (CFI)
563K followers
Valuation multiples are a cornerstone of company analysis, but applying them effectively requires an understanding of how each one works. This breakdown covers the key metrics analysts rely on every day to assess value. 1️⃣ Equity Multiples 2️⃣ Enterprise Value Multiples 3️⃣ Comps & Precedents Swipe through to see how each multiple works, when to use it, and the advantages and limitations of each method. 👉 Follow CFI for clearer, practical insights that strengthen your valuation and modeling skills. #Valuation #CorporateFinance #FinancialModeling #InvestmentBanking #FMVA #Finance #BusinessValuation #EquityResearch #FinancialAnalysis #CFI
630
15 Comments -
Clearly Acquired
1K followers
Small business M&A has never been more critical—and never more constrained by outdated systems. Millions of owners are preparing to exit. Buyers and executives are pouring into acquisition entrepreneurship. Lending capacity continues to expand. Private investors want exposure to real cash-flowing assets. Yet the process of finding a business for sale, relying on a business broker, or securing a business acquisition loan remains slow, fragmented, and opaque. Clearly Acquired was built to solve these problems—through technology, underwriting intelligence, and a fully integrated acquisition platform. https://lnkd.in/gB3a_Twh
5
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content